ALPS Medical Breakthroughs ETFALPS Medical Breakthroughs ETFALPS Medical Breakthroughs ETF

ALPS Medical Breakthroughs ETF

No trades
See on Supercharts

ALPS Medical Breakthroughs ETF holdings


As of July 9, 2025
Symbol
Weight %
Shares
Market value
R
RYTMRhythm Pharmaceuticals, Inc.
3.53%
‪‪31.26 K‬‬
‪‪2.78 M‬‬USD
A
AXSMAxsome Therapeutics, Inc.
3.46%
‪‪24.28 K‬‬
‪‪2.73 M‬‬USD
N
NUVLNuvalent, Inc. Class A
3.39%
‪‪32.74 K‬‬
‪‪2.67 M‬‬USD
A
ALKSAlkermes Public Limited Company
3.10%
‪‪81.36 K‬‬
‪‪2.44 M‬‬USD
P
PCVXVaxcyte, Inc.
2.89%
‪‪63.71 K‬‬
‪‪2.28 M‬‬USD
C
CYTKCytokinetics, Incorporated
2.74%
‪‪58.92 K‬‬
‪‪2.16 M‬‬USD
K
KRYSKrystal Biotech, Inc.
2.68%
‪‪14.20 K‬‬
‪‪2.11 M‬‬USD
A
AKROAkero Therapeutics, Inc.
2.55%
‪‪39.27 K‬‬
‪‪2.01 M‬‬USD
M
MRUSMerus N.V.
2.54%
‪‪36.71 K‬‬
‪‪2.00 M‬‬USD
Z
ZLABZai Lab Ltd. Sponsored ADR
2.52%
‪‪55.64 K‬‬
‪‪1.98 M‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.